Dilantin and Soliris drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dilantin (phenytoin sodium) and Soliris (eculizumab). Common drug interactions include upper respiratory tract infection among females and haemoglobin decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Dilantin and Soliris. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Dilantin?
Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,858 Dilantin users. Check the latest studies of Dilantin.
What is Soliris?
Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.
18 people who take Dilantin and Soliris together, and have interactions are studied.

What are the common drug interactions of Dilantin and Soliris, by gender? *:
female:
- Upper respiratory tract infection
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Anxiety
- Arteriovenous fistula site infection
- Oedema (fluid collection in tissue)
- Somnolence (a state of near-sleep, a strong desire for sleep)
male:
- Haemoglobin decreased
- Drug ineffective
- Burning sensation
- Chills (felling of cold)
- Decreased appetite
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Fall
- Memory impairment
- Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
- Neutropenia (an abnormally low number of neutrophils)
What are the common drug interactions of Dilantin and Soliris, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Chills (felling of cold)
- Neutropenia (an abnormally low number of neutrophils)
30-39:
- Drug ineffective
- Haemoglobin decreased
- Infection
- Influenza
- Platelet count decreased
- Sinusitis (inflammation of sinus)
40-49:
- Anxiety
- Arteriovenous fistula site infection
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Oedema (fluid collection in tissue)
- Somnolence (a state of near-sleep, a strong desire for sleep)
50-59:
n/a
60+:
- Anaemia (lack of blood)
- Upper respiratory tract infection
- Memory impairment
- Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
- Pain in extremity
- Pneumonia
- Ventricular extrasystoles (premature cardiac contraction)
- Visual field defect
- Weight decreased
- Blood lactate dehydrogenase increased
What are the existing conditions these people have? *
- Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 13 people, 72.22%
- Pain: 4 people, 22.22%
- Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 4 people, 22.22%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 16.67%
- Constipation: 2 people, 11.11%
- Nausea (feeling of having an urge to vomit): 2 people, 11.11%
- Headache (pain in head): 2 people, 11.11%
- Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 1 person, 5.56%
- Diabetes: 1 person, 5.56%
- Fever: 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Dilantin and Soliris?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Dilantin and Soliris:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dilantin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Soliris:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dilantin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Soliris and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on phenytoin sodium and eculizumab (the active ingredients of Dilantin and Soliris, respectively), and Dilantin and Soliris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cellcept and Stress for Men aged 50-59 - now
- Cellcept and Anxiety, Apprehension, Feeling Uptight, Jitters, Stress, Stress And Anxiety, Tension for Men aged 50-59 - now
- Cellcept and Jitters for Men aged 50-59 - a second ago
- Cellcept and Feeling Uptight for Men aged 50-59 - a second ago
- Cellcept and Apprehension for Men aged 50-59 - a second ago
- Cellcept and Anxiety for Men aged 50-59 - 2 seconds ago
- Cellcept and Stress And Anxiety for Men aged 50-59 - 2 seconds ago
- Drug interactions of Harvoni and Zestril - 2 seconds ago
- Guillain-Barre Syndrome and drugs of ingredients of zoledronic acid - 5 seconds ago
- Guillain Barre Syndrome and drugs of ingredients of zoledronic acid - 5 seconds ago